{"id":30196,"date":"2025-09-17T06:40:27","date_gmt":"2025-09-17T06:40:27","guid":{"rendered":"https:\/\/www.euegeajans.com\/?p=30196"},"modified":"2025-09-17T06:40:47","modified_gmt":"2025-09-17T06:40:47","slug":"meme-kanserinin-erken-evrede-dogru-teshis-ve-tedavisine-yonelik-proje","status":"publish","type":"post","link":"https:\/\/www.euegeajans.com\/index.php\/2025\/09\/17\/meme-kanserinin-erken-evrede-dogru-teshis-ve-tedavisine-yonelik-proje\/","title":{"rendered":"Meme kanserinin erken evrede do\u011fru te\u015fhis ve tedavisine y\u00f6nelik proje"},"content":{"rendered":"

Egeli bilim insan\u0131 Do\u00e7. Dr. Ekinci\u2019nin sa\u011fl\u0131k temal\u0131 yenilik\u00e7i projesine T\u00dcB\u0130TAK\u2019tan destek<\/strong><\/p>\n

Ege \u00dcniversitesi (E\u00dc) Eczac\u0131l\u0131k Fak\u00fcltesi Eczac\u0131l\u0131k Teknolojisi B\u00f6l\u00fcm\u00fc Radyofarmasi Anabilim Dal\u0131 \u00f6\u011fretim \u00fcyesi Do\u00e7. Dr. Meliha Ekinci\u2019nin y\u00fcr\u00fct\u00fcc\u00fcl\u00fc\u011f\u00fcn\u00fc yapt\u0131\u011f\u0131 \u201c99mTc ile i\u015faretli lapatinib ditosilat i\u00e7eren nanopartik\u00fcllerin meme kanserini g\u00f6r\u00fcnt\u00fcleme potansiyelinin in vitro ve in vivo \u00e7al\u0131\u015fmalar ile ara\u015ft\u0131r\u0131lmas\u0131\u201d ba\u015fl\u0131kl\u0131 proje, T\u00dcB\u0130TAK 1002-A H\u0131zl\u0131 Destek Program\u0131 kapsam\u0131nda desteklenmeye uygun bulundu.<\/p>\n

Proje kapsam\u0131nda, meme kanserine y\u00f6nelik erken te\u015fhise katk\u0131 sa\u011flamak amac\u0131yla, HER2 pozitif meme kanserinin tan\u0131s\u0131nda kullan\u0131labilecek yeni bir radyofarmas\u00f6tik geli\u015ftirilmesi hedefleniyor.<\/p>\n

Ege \u00dcniversitesi Rekt\u00f6r\u00fc Prof. Dr. Necdet Budak, \u201cTam akredite, sa\u011fl\u0131k temal\u0131 ara\u015ft\u0131rma \u00fcniversitemiz, sa\u011fl\u0131k alan\u0131nda yenilik\u00e7i projeler \u00fcretmeye devam ediyor. Bu de\u011ferli \u00e7al\u0131\u015fmalar, \u00fcniversitemizin ara\u015ft\u0131rma ve inovasyon vizyonuna \u00f6nemli katk\u0131lar sunuyor.\u00a0Kad\u0131nlarda en s\u0131k g\u00f6r\u00fclen kanser t\u00fcr\u00fc olan meme kanserinin erken tan\u0131s\u0131na y\u00f6nelik ger\u00e7ekle\u015ftirdikleri projeleri T\u00dcB\u0130TAK taraf\u0131ndan kabul g\u00f6ren Eczac\u0131l\u0131k Fak\u00fcltesi \u00f6\u011fretim \u00fcyemiz Do\u00e7. Dr. Meliha Ekinci ve ekibini tebrik ediyor, ba\u015far\u0131lar\u0131n\u0131n devam\u0131n\u0131 diliyorum\u201d dedi.<\/p>\n

Proje hakk\u0131nda bilgi veren Do\u00e7. Dr. Meliha Ekinci, \u201cHER2 resept\u00f6r\u00fcne y\u00fcksek afinite g\u00f6steren ve meme kanseri tedavisinde FDA onayl\u0131 bir tirozin kinaz inhibit\u00f6r\u00fc olarak kullan\u0131lan lapatinib ditosilat i\u00e7eren nanopartik\u00fcler form\u00fclasyonlar\u0131, 99mTc ile radyoi\u015faretleyerek \u201899mTc-lapatinib ditosilat nanopartik\u00fcl\u00fc\u2019 formunda yeni bir radyofarmas\u00f6tik geli\u015ftirmeyi hedefliyoruz. Bu yeni radyofarmas\u00f6ti\u011fin, h\u00fccre k\u00fclt\u00fcr\u00fc ve in vivo biyoda\u011f\u0131l\u0131m \u00e7al\u0131\u015fmalar\u0131 ile meme kanseri h\u00fccrelerine olan afinitesini de\u011ferlendirece\u011fiz. Projemizle, kanserin erken evrede do\u011fru te\u015fhis ve tedavisinin \u00f6nemine vurgu yaparak, sintigrafik g\u00f6r\u00fcnt\u00fcleme gibi fizyolojik de\u011fi\u015fiklikleri tespit etmeye y\u00f6nelik non-invaziv g\u00f6r\u00fcnt\u00fcleme tekniklerinin tan\u0131daki etkinli\u011fini art\u0131rmay\u0131 ama\u00e7l\u0131yoruz\u201d dedi.<\/p>\n","protected":false},"excerpt":{"rendered":"

Egeli bilim insan\u0131 Do\u00e7. Dr. Ekinci\u2019nin sa\u011fl\u0131k temal\u0131 yenilik\u00e7i projesine T\u00dcB\u0130TAK\u2019tan destek Ege \u00dcniversitesi (E\u00dc)…<\/p>\n","protected":false},"author":2,"featured_media":30197,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[69,99,1,68],"tags":[],"class_list":["post-30196","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-bilim","category-egitim","category-gncl","category-saglik"],"featured_image_urls":{"full":["https:\/\/www.euegeajans.com\/wp-content\/uploads\/2025\/09\/Prof.-Dr.-Necdet-Budak-Doc.-Dr.-Meliha-Ekinci-1.jpg",1500,1000,false],"thumbnail":["https:\/\/www.euegeajans.com\/wp-content\/uploads\/2025\/09\/Prof.-Dr.-Necdet-Budak-Doc.-Dr.-Meliha-Ekinci-1-150x150.jpg",150,150,true],"medium":["https:\/\/www.euegeajans.com\/wp-content\/uploads\/2025\/09\/Prof.-Dr.-Necdet-Budak-Doc.-Dr.-Meliha-Ekinci-1-300x200.jpg",300,200,true],"medium_large":["https:\/\/www.euegeajans.com\/wp-content\/uploads\/2025\/09\/Prof.-Dr.-Necdet-Budak-Doc.-Dr.-Meliha-Ekinci-1-768x512.jpg",640,427,true],"large":["https:\/\/www.euegeajans.com\/wp-content\/uploads\/2025\/09\/Prof.-Dr.-Necdet-Budak-Doc.-Dr.-Meliha-Ekinci-1-1024x683.jpg",640,427,true],"1536x1536":["https:\/\/www.euegeajans.com\/wp-content\/uploads\/2025\/09\/Prof.-Dr.-Necdet-Budak-Doc.-Dr.-Meliha-Ekinci-1.jpg",1500,1000,false],"2048x2048":["https:\/\/www.euegeajans.com\/wp-content\/uploads\/2025\/09\/Prof.-Dr.-Necdet-Budak-Doc.-Dr.-Meliha-Ekinci-1.jpg",1500,1000,false],"newsphere-slider-full":["https:\/\/www.euegeajans.com\/wp-content\/uploads\/2025\/09\/Prof.-Dr.-Necdet-Budak-Doc.-Dr.-Meliha-Ekinci-1-1280x720.jpg",1280,720,true],"newsphere-featured":["https:\/\/www.euegeajans.com\/wp-content\/uploads\/2025\/09\/Prof.-Dr.-Necdet-Budak-Doc.-Dr.-Meliha-Ekinci-1-1024x683.jpg",1024,683,true],"newsphere-medium":["https:\/\/www.euegeajans.com\/wp-content\/uploads\/2025\/09\/Prof.-Dr.-Necdet-Budak-Doc.-Dr.-Meliha-Ekinci-1-720x380.jpg",720,380,true]},"author_info":{"display_name":"Editor","author_link":"https:\/\/www.euegeajans.com\/index.php\/author\/editor\/"},"category_info":"Bilim<\/a> E\u011fitim<\/a> G\u00fcncel<\/a> Sa\u011fl\u0131k<\/a>","tag_info":"Sa\u011fl\u0131k","comment_count":"0","_links":{"self":[{"href":"https:\/\/www.euegeajans.com\/index.php\/wp-json\/wp\/v2\/posts\/30196","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.euegeajans.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euegeajans.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euegeajans.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euegeajans.com\/index.php\/wp-json\/wp\/v2\/comments?post=30196"}],"version-history":[{"count":2,"href":"https:\/\/www.euegeajans.com\/index.php\/wp-json\/wp\/v2\/posts\/30196\/revisions"}],"predecessor-version":[{"id":30199,"href":"https:\/\/www.euegeajans.com\/index.php\/wp-json\/wp\/v2\/posts\/30196\/revisions\/30199"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.euegeajans.com\/index.php\/wp-json\/wp\/v2\/media\/30197"}],"wp:attachment":[{"href":"https:\/\/www.euegeajans.com\/index.php\/wp-json\/wp\/v2\/media?parent=30196"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euegeajans.com\/index.php\/wp-json\/wp\/v2\/categories?post=30196"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euegeajans.com\/index.php\/wp-json\/wp\/v2\/tags?post=30196"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}